U.S. market Closed. Opens in 10 hours 33 minutes

NVNO | enVVeno Medical Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
RevenueN/AN/AN/AN/A31.24K186.55K422.11K785.91KN/A236.50K
Cost of Revenue546.00K525.00K452.91K383.97KN/AN/A419.66K810.29K125.42K132.31K
Gross Profit-546.00K-525.00K-452.91K-383.97K31.24K186.55K2.45K-24.38K-125.42K104.19K
Operating Expenses25.24M24.93M16.89M9.14M7.12M7.72M6.11M4.63M1.29M1.06M
Selling, General & Admin11.65M15.02M11.16M4.88M4.91M6.48M5.46M4.63M1.29M1.06M
Research & Development13.58M9.91M5.73M4.25M2.21M1.24M649.74KN/AN/AN/A
Other Operating ExpensesN/AN/A33.27K-215.91KN/AN/AN/AN/AN/AN/A
Operating Income-25.24M-24.93M-16.89M-9.14M-7.68M-7.85M-6.10M-4.66M-1.29M-952.66K
Other Expenses / Income1.72M263.00K364.68K-360.0049.91K-5.19M-1.69M-929.08K-88.35K-65.49K
Before Tax Income-23.52M-24.67M-16.53M-9.14M-7.63M-13.04M-7.79M-5.59M-1.38M-1.02M
Income Tax ExpensesN/A-365.00K-331.41K-215.55K863.54K1.67M209.51K-2.14M314.34KN/A
Net Income-23.52M-24.30M-16.20M-8.92M-7.63M-13.04M-7.79M-3.39M-1.60M-1.02M
Interest ExpensesN/AN/AN/AN/AN/A6.86M209.51K57.89K88.52KN/A
Basic Shares Outstanding12.30M11.23M8.68M1.29M630.42K374.50K387.69K438.72K438.72K239.00K
Diluted Shares Outstanding12.30M11.23M8.68M1.29M630.42K374.50K387.69K438.72K438.72K240.00K
EBITDA-25.02M-24.51M-16.75M-8.75M-6.96M-6.05M-5.73M-5.38M-1.16M-818.53K
EBITDA Margin0.00%0.00%0.00%0.00%-22,286.05%-3,242.20%-1,358.08%-684.45%0.00%-346.10%
EBIT-23.52M-24.67M-16.53M-9.14M-6.76M-4.51M-7.37M-5.47M-1.20M-1.02M
EBIT Margin0.00%0.00%0.00%0.00%-21,642.78%-2,416.93%-1,746.57%-696.32%0.00%-430.51%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙